- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
 |
| Quantity: | |
|---|---|
Ciprofibrate is a raw material for phenoxyacetic acid based lipid-lowering drugs, and is an intermediate of lipid-lowering drugs. It is structurally related to clopidogrel. It has a lipid-lowering effect, which is stronger than the effect of clopidogrel. It can significantly reduce the levels of very low density and low-density lipoprotein, and increase high-density lipoprotein. By improving the distribution of cholesterol, the deposition of CH and LDL on the blood vessel wall can be reduced. It also has the effects of dissolving fibrin and preventing platelet aggregation.
Ciprofibrate is a raw material for phenoxyacetic acid based lipid-lowering drugs, and is an intermediate of lipid-lowering drugs. It is structurally related to clopidogrel. It has a lipid-lowering effect, which is stronger than the effect of clopidogrel. It can significantly reduce the levels of very low density and low-density lipoprotein, and increase high-density lipoprotein. By improving the distribution of cholesterol, the deposition of CH and LDL on the blood vessel wall can be reduced. It also has the effects of dissolving fibrin and preventing platelet aggregation.
